Stem Cell Research (Mar 2023)

An induced pluripotent stem cell line (MUSIi019-A) generated from a patient with distal renal tubular acidosis carrying a compound heterozygous mutation in solute carrier family 4 member 1 (SLC4A1) gene

  • Narissara Kaewboonlert,
  • Methichit Wattanapanitch,
  • Oranud Praditsap,
  • Nipaporn Deejai,
  • Chutima Chanprasert,
  • Nunghathai Sawasdee,
  • Choochai Nettuwakul,
  • Wanchai Wanachiwanawin,
  • Suchai Sritippayawan,
  • Prapaporn Jungtrakoon Thamtarana,
  • Pa-thai Yenchitsomanus,
  • Nanyawan Rungroj

Journal volume & issue
Vol. 67
p. 103043

Abstract

Read online

Distal renal tubular acidosis (dRTA), a disease characterized by the failure of the distal nephron to secrete acid into the urine, can be caused by mutations in SLC4A1 gene encoding erythroid and kidney anion exchanger 1 (AE1). Here, an induced pluripotent stem cell (iPSC) line was generated from a patient with dRTA and hemolytic anemia carrying compound heterozygous SLC4A1 mutations containing c.1199_1225del (p.Ala400_Ala408del), resulting in Southeast Asian ovalocytosis (SAO), and c.1331C>A (p.Thr444Asn). Peripheral blood mononuclear cells (PBMCs) were reprogrammed using Sendai viral reprogramming. The established iPSC line, MUSIi019-A, exhibited pluripotent property and retained the same mutations observed in the patients.

Keywords